Columbia University

Mission Statement

The mission of the Irving Institute for Clinical and Translational Research is to advance discoveries, knowledge, and innovation to improve human health across the lifespan for diverse populations in upper Manhattan and around the world. By mobilizing and connecting Columbia University’s researchers, we aim to create a seamless integration of community and academic partnerships. Our commitment to train a multi-faceted workforce, provide vital resources to researchers, and improve the efficiency of research processes, promotes the collaborative team science framework needed to translate research discoveries into effective interventions that address current and future health concerns.

We provide over 70 different services and programs focused on education and training, seed funding, bioinformatics, biostatistics, clinical research, lifespan research and special populations, regulatory knowledge and bioethics, an off-site community facility and health informatics websites.

At a Glance


Educational Resources Posted


Consortium News Stories Posted


Events Posted


Opportunities Posted


Publications citing CTSA Program Grant


Users from Hub Registered

UL1 Award

KL2 Award

TL1 Award

Funded Years
2012 - 2020
Connect with Us

Consortium News

The grant, awarded by the National Institutes of Health, is one of the largest ever to the medical school. It will support the work of the Irving Institute for Clinical and Translational Research, led by Muredach Reilly, MBBCh, MSCE, professor of medicine and associate dean for clinical and translational research. The Institute works in partnership with researchers and clinicians across Columbia

A discussion with Andrea Califano and narrative medicine writer, Rita Charon: Art and science unfold in time as chronological sightings overturn until-then received knowledge—from the epic to the novel, from classical portraiture to cubism, from before Copernicus to after Copernicus. Art and science unfold in space as discoverers choose a scale and a scope—from parole to langue, from harmony to

The Irving Institute for Clinical and Translational Research, Columbia University's CTSA Hub, has partnered with Rita Charon on a new narrative medicine series, interviewing today’s leading life scientists. "The effective practice of medicine requires narrative competence, that is, the ability to acknowledge, absorb, interpret, and act on the stories and plights of others. Medicine practiced with

Educational Content

Columbia University Health Sciences

This course has been recorded and the full video series is now available online. Taught via Zoom at Columbia University, Fall 2020. Intellectual property (patents, copyrights, trademarks) are an increasingly critical part of almost any business, at almost any stage of growth. This course provides the aspiring business executive, entrepreneur, or scientist an overview of commercial opportunities

Columbia University Health Sciences
The Columbia Lab-to-Market: Life Science Accelerator Program comprised of the Translational Therapeutics Accelerator (TRx), Accelerating Cancer Therapeutics (ACT), and the Biomedical Technology Accelerator (BiomedX). About the Course: This course is a series of evening sessions designed to provide specialized frameworks and essential tools to investigator teams (clinicians, engineers, scientists)
Columbia University Health Sciences

These stand-alone workshops precede the May 6th-7th conference for best practices in representation & reasoning. The workshops have separate calls for papers and their own program and organizing committee. The tutorials are half-day learning sessions that include both lecture style and hands-on sessions. Early bird registration ends Feb 15, 2020!


The Irving Institute for Clinical and Translational Research, home of the Columbia University CTSA Hub, is offering - TL1 Training Program Now Accepting Applications The TL1 Training Programs are intended to provide trainees with additional research training to prepare for a research career that can contribute in some meaningful way to understanding risk of disease, improving diagnosis and

Poster Sessions

Columbia University Health Sciences

The Irving Institute for Clinical and Translational Research (IICTR), home to Columbia University’s CTSA Program Hub, supports a mission of bringing novel innovations to patients through education, mentorship and pilot award funding through the Accelerate program. The Accelerate program leverages Columbia University’s proficiency in drug discovery and provides access to entrepreneurs and industry

Columbia University Health Sciences
Columbia University CTSA Program Hub Innovations:​ Operating a Clinical Research Unit in the COVID-19 Era and Building a COVID-19 Biobank​ Heather Seid, MS, RDN (1); Sheila O’Byrne, PhD (2); Elisabeth DiMaria, MHA (1); Ismael Castaneda, MS, BSN (1); Dianne Frederick (1); Janelle Nunez (1); Ariella Kelin, MSRN (3); Josh Wansley, MSRN (3); Danielle Pendrick, DrPH (4); Jennifer Williamson, MS, MPH (5
Columbia University Fall 2019 Poster
Columbia University Health Sciences

The Irving Institute for Clinical and Translational Research, home to Columbia University’s CTSA Program Hub, provides resources to investigators in the areas of precision medicine and translational research through two unique resources focused on providing funding, education, research services, and mentorship programs to support advancement of projects. The Translational Therapeutics (TRx)


Group-randomized trial of tailored brief shared decision-making to improve asthma control in urban black adults

To assess the intervention effects of BREATHE (BRief intervention to Evaluate Asthma THErapy), a novel brief shared decision-making intervention and evaluate feasibility and acceptability of intervention procedures. Group-randomized longitudinal pilot study. In total, 80 adults with uncontrolled

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion

MicroRNAs (miRs) have been shown to play an important role in tumorigenesis, including in head and neck squamous cell carcinoma (HNSCC). The miR-34 family is thought to play a role in tumor suppression, but the exact mechanism of their action in HNSCC is not well understood. Moreover, the impact of

Research and Operational Tools

Columbia University Health Sciences

Learning the Ropes - Irving Institute’s Translational Therapeutics Accelerator (TRx) Helps Researchers Navigate the Challenges of Commercialization

Title Authored Sort ascending Content type
Diversity, Equity and Inclusion in Commercialization and Entrepreneurship within Columbia’s Accelerate Resource November 05, 2021 Poster
Columbia Awarded $61.7 Million to Accelerate Development of New Medical Treatments September 14, 2021 Consortium News
How to Navigate the Challenges of Commercialization July 29, 2021 Research or Operational Tool
Narratives of Discovery: "The Golden Age of Biology" - Andrea Califano July 26, 2021 Consortium News
Columbia University: IP for Entrepreneurs Course - Video Series April 13, 2021 Educational Content
A Narrative Medicine Approach for Exploring Clinical Research April 01, 2021 Consortium News
TL1 Training Program March 08, 2021 Opportunity
Columbia University CTSA Supports Community Food Bank December 29, 2020 Consortium News
Improving Careers in Clinical & Translational Research Common Metric within the KL2 Women’s Measure October 29, 2020 Consortium News
Columbia University CTSA Program Hub Innovations: Operating a Clinical Research Unit in the COVID-19 Era and Building a COVID-19 Biobank October 22, 2020 Poster
#20SegundosOMas - PSA for COVID-19 July 16, 2020 Consortium News
Knowledge Graph Conference (KGC) Workshops & Tutorials February 03, 2020 Event
Columbia University Precision Medicine Resource Co-Directors Launch Annals of Internal Medicine Article Series November 15, 2019 Consortium News
Precision Medicine Pilot Award Findings Published in New England Journal of Medicine November 15, 2019 Consortium News
Life Science Accelerator Boot Camp September 12, 2019 Educational Content
Columbia University CTSA Program Hub Optional Cores: Translational Therapeutics Accelerator and Precision Medicine Resource August 20, 2019 Poster